DWTX

Dogwood Therapeutics, Inc. DWTX

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$6.16M total
ARMISTICE CAPITAL, LLC
$5.04M-4.5%
MILLENNIUM MANAGEMENT LLC
$550.3KNew
VANGUARD CAPITAL MANAGEMENT LLC
$212.8K0.0%
GEODE CAPITAL MANAGEMENT, LLC
$142.2K+11.2%
VANGUARD FIDUCIARY TRUST CO
$101.0K0.0%
BlackRock, Inc.
$46.0KNew
NORTHERN TRUST CORP
$38.3K0.0%
CITADEL ADVISORS LLC
$18.9KNew
Tower Research Capital LLC (TRC)
$5.0K-61.7%
MORGAN STANLEY
$3.6KNew
UBS Group AG
$3.0K-73.7%
JONES FINANCIAL COMPANIES LLLP
$264New
BARCLAYS PLC
$253New
Activest Wealth Management
$1930.0%
GROUP ONE TRADING, L.P.
$140.0%
See all 15 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/DWTX

Earnings Per Share

13fpro.ai/company/DWTX

Loading ratio trend…

DWTX insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Dogwood Therapeutics, Inc. (DWTX): stock profile, AI score and financials

Dogwood Therapeutics, Inc. (DWTX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. DWTX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of DWTX by reported 13-F value include ARMISTICE CAPITAL, MILLENNIUM MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. DWTX trades on the Nasdaq exchange and files with the SEC under CIK 1818844. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DWTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Dogwood Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1818844 →